Drug profile · INN
dolutegravir and lamivudine
DOLUTEGRAVIR AND LAMIVUDINE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
dolutegravir and lamivudine (DOLUTEGRAVIR AND LAMIVUDINE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN dolutegravir and lamivudine
Brand DOLUTEGRAVIR AND LAMIVUDINE
Formulation TABLET
Frequently asked questions
What is dolutegravir and lamivudine?
dolutegravir and lamivudine (DOLUTEGRAVIR AND LAMIVUDINE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for dolutegravir and lamivudine?
DOLUTEGRAVIR AND LAMIVUDINE is a marketed brand name for dolutegravir and lamivudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dolutegravir and lamivudine?
dolutegravir and lamivudine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.